Phase II trial of a syllable-timed speech treatment for school-age children who stutter

Andrews, C; O'Brian, S; Onslow, M; Packman, A; Menzies, R; Lowe, R

Phase II trial of a syllable-timed speech treatment for school-age children who stutter

Andrews, C O'Brian, S

Onslow, M

Packman, A

Menzies, R

Lowe, R

Permalink

Publisher:: ELSEVIER SCIENCE INC
Publication Type:: Journal Article
Citation:: Journal of Fluency Disorders, 2016, 48, pp. 44-55
Issue Date:: 2016-06-01

Closed Access

	Filename	Description	Size
	1-s2.0-S0094730X16300079-main.pdf	Published version	806.2 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Andrews, C
dc.contributor.author	O'Brian, S https://orcid.org/0000-0002-0882-1909
dc.contributor.author	Onslow, M https://orcid.org/0000-0003-2629-2390
dc.contributor.author	Packman, A https://orcid.org/0000-0001-7378-326X
dc.contributor.author	Menzies, R https://orcid.org/0000-0002-7589-960X
dc.contributor.author	Lowe, R https://orcid.org/0000-0003-3826-5306
dc.date.accessioned	2022-07-29T20:24:30Z
dc.date.available	2016-06-16
dc.date.available	2022-07-29T20:24:30Z
dc.date.issued	2016-06-01
dc.identifier.citation	Journal of Fluency Disorders, 2016, 48, pp. 44-55
dc.identifier.issn	0094-730X
dc.identifier.issn	1873-801X
dc.identifier.uri	http://hdl.handle.net/10453/159366
dc.description.abstract	© 2016 Elsevier Inc. Purpose A recent clinical trial (Andrews et al., 2012) showed Syllable Timed Speech (STS) to be a potentially useful treatment agent for the reduction of stuttering for school-age children. The present trial investigated a modified version of this program that incorporated parent verbal contingencies. Methods Participants were 22 stuttering children aged 6–11 years. Treatment involved training the children and their parents to use STS in conversation. Parents were also taught to use verbal contingencies in response to their child's stuttered and stutter-free speech and to praise their child's use of STS. Outcome assessments were conducted pre-treatment, at the completion of Stage 1 of the program and 6 months and 12 months after Stage 1 completion. Results Outcomes are reported for the 19 children who completed Stage 1 of the program. The group mean percent stuttering reduction was 77% from pre-treatment to 12 months post-treatment, and 82% with the two least responsive participants removed. There was considerable variation in response to the treatment. Seventeen of the children showed reduced avoidance of speaking situations and 18 were more satisfied with their fluency post-treatment. However, there was some suggestion that stuttering control was not sufficient to fully eliminate situation avoidance for the children. Conclusions The results of this trial are sufficiently encouraging to warrant further clinical trials of the method. Educational objectives The reader will be able to: (a) discuss the reasons for investigating a new treatment for school-age children; (b) describe the main components of the STS treatment; (c) summarize the results of this clinical trial; (d) discuss the outcomes of this trial in relation to current theory
dc.format	Print-Electronic
dc.language	eng
dc.publisher	ELSEVIER SCIENCE INC
dc.relation	http://purl.org/au-research/grants/nhmrc/633007
dc.relation.ispartof	Journal of Fluency Disorders
dc.relation.isbasedon	10.1016/j.jfludis.2016.06.001
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	11 Medical and Health Sciences, 17 Psychology and Cognitive Sciences, 20 Language, Communication and Culture
dc.subject.classification	Speech-Language Pathology & Audiology
dc.subject.mesh	Child
dc.subject.mesh	Female
dc.subject.mesh	Humans
dc.subject.mesh	Male
dc.subject.mesh	Parents
dc.subject.mesh	Speech
dc.subject.mesh	Speech Production Measurement
dc.subject.mesh	Speech Therapy
dc.subject.mesh	Stuttering
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Humans
dc.subject.mesh	Stuttering
dc.subject.mesh	Speech Production Measurement
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Speech Therapy
dc.subject.mesh	Speech
dc.subject.mesh	Parents
dc.subject.mesh	Child
dc.subject.mesh	Female
dc.subject.mesh	Male
dc.title	Phase II trial of a syllable-timed speech treatment for school-age children who stutter
dc.type	Journal Article
utslib.citation.volume	48
utslib.location.activity	United States
utslib.for	11 Medical and Health Sciences
utslib.for	17 Psychology and Cognitive Sciences
utslib.for	20 Language, Communication and Culture
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - ASRC Australian Stuttering Research Centre
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Australian Stuttering Research Centre
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2022-07-29T20:24:29Z
pubs.publication-status	Published
pubs.volume	48

Abstract:

© 2016 Elsevier Inc. Purpose A recent clinical trial (Andrews et al., 2012) showed Syllable Timed Speech (STS) to be a potentially useful treatment agent for the reduction of stuttering for school-age children. The present trial investigated a modified version of this program that incorporated parent verbal contingencies. Methods Participants were 22 stuttering children aged 6–11 years. Treatment involved training the children and their parents to use STS in conversation. Parents were also taught to use verbal contingencies in response to their child's stuttered and stutter-free speech and to praise their child's use of STS. Outcome assessments were conducted pre-treatment, at the completion of Stage 1 of the program and 6 months and 12 months after Stage 1 completion. Results Outcomes are reported for the 19 children who completed Stage 1 of the program. The group mean percent stuttering reduction was 77% from pre-treatment to 12 months post-treatment, and 82% with the two least responsive participants removed. There was considerable variation in response to the treatment. Seventeen of the children showed reduced avoidance of speaking situations and 18 were more satisfied with their fluency post-treatment. However, there was some suggestion that stuttering control was not sufficient to fully eliminate situation avoidance for the children. Conclusions The results of this trial are sufficiently encouraging to warrant further clinical trials of the method. Educational objectives The reader will be able to: (a) discuss the reasons for investigating a new treatment for school-age children; (b) describe the main components of the STS treatment; (c) summarize the results of this clinical trial; (d) discuss the outcomes of this trial in relation to current theory

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/159366